É. Lemarié

2.7k total citations
105 papers, 1.9k citations indexed

About

É. Lemarié is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, É. Lemarié has authored 105 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 15 papers in Epidemiology. Recurrent topics in É. Lemarié's work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (16 papers) and Inhalation and Respiratory Drug Delivery (15 papers). É. Lemarié is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Research Studies (16 papers) and Inhalation and Respiratory Drug Delivery (15 papers). É. Lemarié collaborates with scholars based in France, Switzerland and Poland. É. Lemarié's co-authors include A Depierre, P. Diot, P. Jacoulet, G Dabouis, Élisabeth Quoix, J.C. Dalphin, B. Milleron, E Boissinot, A. Le Pape and Jean-Luc Breton and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

É. Lemarié

95 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
É. Lemarié France 22 1.1k 929 334 306 139 105 1.9k
Saul Yanovich United States 23 579 0.5× 887 1.0× 382 1.1× 263 0.9× 121 0.9× 47 2.0k
Hiroichi Ishikawa Japan 23 1.1k 1.0× 717 0.8× 284 0.9× 381 1.2× 72 0.5× 132 2.0k
Reury-Perng Perng Taiwan 26 1.6k 1.4× 1.1k 1.2× 365 1.1× 252 0.8× 103 0.7× 78 2.3k
R.M. Rudd United Kingdom 27 2.0k 1.8× 1.1k 1.1× 470 1.4× 336 1.1× 194 1.4× 70 2.8k
Rasim Gucalp United States 24 628 0.6× 1.1k 1.2× 269 0.8× 187 0.6× 113 0.8× 87 1.7k
T. Beinert Germany 23 772 0.7× 255 0.3× 231 0.7× 205 0.7× 139 1.0× 68 1.3k
Atsuhisa Tamura Japan 17 962 0.9× 632 0.7× 133 0.4× 353 1.2× 44 0.3× 76 1.6k
William G. Hocking United States 18 1.4k 1.2× 613 0.7× 222 0.7× 181 0.6× 133 1.0× 48 2.3k
Sow-Hsong Kuo Taiwan 25 1.2k 1.0× 434 0.5× 423 1.3× 214 0.7× 93 0.7× 70 2.1k
Ji Yun Lee South Korea 24 662 0.6× 708 0.8× 437 1.3× 321 1.0× 160 1.2× 105 1.9k

Countries citing papers authored by É. Lemarié

Since Specialization
Citations

This map shows the geographic impact of É. Lemarié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Lemarié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Lemarié more than expected).

Fields of papers citing papers by É. Lemarié

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Lemarié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Lemarié. The network helps show where É. Lemarié may publish in the future.

Co-authorship network of co-authors of É. Lemarié

This figure shows the co-authorship network connecting the top 25 collaborators of É. Lemarié. A scholar is included among the top collaborators of É. Lemarié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with É. Lemarié. É. Lemarié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guilleminault, Laurent, É. Lemarié, & Nathalie Heuzé‐Vourc'h. (2012). Monoclonal Antibodies: An Emerging Class of Therapeutics in Non Small Cell Lung Cancer. Journal of Cancer Therapy. 3(6). 1170–1190. 3 indexed citations
2.
Quoix, Élisabeth & É. Lemarié. (2011). Épidémiologie du cancer bronchique primitif : aspects classiques et nouveautés. Revue des Maladies Respiratoires. 28(8). 1048–1058. 16 indexed citations
3.
Duchange, Nathalie, S. Chapet, Étienne Dorval, et al.. (2010). La réunion de concertation pluridisciplinaire : quelle place dans la décision médicale en cancérologie ?. Bulletin du Cancer. 97(2). 255–264. 20 indexed citations
4.
Iochmann, Sophie, Claire Bléchet, Florent Hubé, et al.. (2005). Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer. British Journal of Cancer. 92(4). 775–783. 64 indexed citations
5.
Pujol, Jean-Louis, Jean-Luc Breton, R. Gervais, et al.. (2005). Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin. Annals of Oncology. 16(4). 602–610. 101 indexed citations
6.
Ferrandière, Martine, et al.. (2004). Diagnostic des pleurésies (hors cancer). Revue des Maladies Respiratoires. 21(6). 1191–1196. 2 indexed citations
7.
Rabbat, Antoine, et al.. (2004). Conduite à tenir devant un pneumothorax spontané et primitif. Revue des Maladies Respiratoires. 21(6). 1187–1190. 4 indexed citations
8.
Treat, Joseph, Joan H. Schiller, Élisabeth Quoix, et al.. (2002). ZD0473 treatment in lung cancer: an overview of the clinical trial results. European Journal of Cancer. 38. S13–S18. 30 indexed citations
9.
Grimbert, Daniel, M.H. Becquemin, E Boissinot, et al.. (2001). Validation of Laser Diffraction Method as a Substitute for Cascade Impaction in the European Project for a Nebulizer Standard. Journal of Aerosol Medicine. 14(1). 107–114. 38 indexed citations
10.
Pujol, Jean-Louis, Jean Pierre Daurès, Aart Brutel de la Rivière, et al.. (2001). Etoposide Plus Cisplatin With or Without the Combination of 4'-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III Randomized Study. JNCI Journal of the National Cancer Institute. 93(4). 300–308. 111 indexed citations
11.
Diot, P., Pierre‐François Dequin, B Rivoire, et al.. (2001). Aerosols and Anti-Infectious Agents. Journal of Aerosol Medicine. 14(1). 55–64. 22 indexed citations
12.
Quoix, Élisabeth, Jean-Luc Breton, Casey L. Daniel, et al.. (2001). Etoposide phosphate with carboplatin in the treatment of elderly patients with small-cell lung cancer: A phase II study. Annals of Oncology. 12(7). 957–962. 38 indexed citations
13.
Mallet, Jean‐Pierre, P. Diot, & É. Lemarié. (1997). [Inhalation route for administration of systemic drugs].. PubMed. 14(4). 257–67. 5 indexed citations
14.
Bacle, Astrid, P. Diot, & É. Lemarié. (1997). Vaccin anti-pneumococcique: justifications et résultats.. Revue de Pneumologie Clinique. 53(3). 4 indexed citations
15.
Ritz, Ludivine, P. Diot, Danielle Degenne, et al.. (1996). L'anticorps anti-topo-isomérase est-il un marqueur de l'atteinte pulmonaire au cours de la sclérodermie systémique ?. La Revue de Médecine Interne. 17. 393s–394s. 1 indexed citations
16.
Lebeau, B, C Chastang, Luc Thiberville, et al.. (1995). Chimiothérapie des cancers bronchiques à petites cellules. Importance pronostique d'une réponse complète (1,280 patients). Groupe Petites Cellules.. La Presse Médicale. 24(4). 2 indexed citations
17.
Diot, P., et al.. (1994). Quantification Of Cell Loss During Bronchoalveolar Lavage Fluid Processing. Effects Of Fixation And Staining Methods. American Journal of Respiratory and Critical Care Medicine. 149(3). 636–640. 16 indexed citations
18.
Depierre, A, et al.. (1989). Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).. PubMed. 16(2 Suppl 4). 26–9. 42 indexed citations
19.
Renoux, M, et al.. (1989). Interleukin-l Secretion by Lipopolysaccharide-Stimulated Alveolar Macrophages. Respiration. 55(3). 158–168. 10 indexed citations
20.
Lemarié, É., et al.. (1986). Disseminated Aspergillosis in a Patient with Bronchiectasis. Respiration. 49(3). 235–240. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saul Yanovich Breakdown of academic impact, for papers by Hiroichi Ishikawa Breakdown of academic impact, for papers by Reury-Perng Perng Breakdown of academic impact, for papers by R.M. Rudd Breakdown of academic impact, for papers by Rasim Gucalp Breakdown of academic impact, for papers by T. Beinert Breakdown of academic impact, for papers by Atsuhisa Tamura Breakdown of academic impact, for papers by William G. Hocking Breakdown of academic impact, for papers by Sow-Hsong Kuo Breakdown of academic impact, for papers by Ji Yun Lee
Rankless by CCL
2026